Enrico Bergonzani
About Enrico Bergonzani
Enrico Bergonzani is a Global Trial Manager at Bristol Myers Squibb in Neuchâtel, Switzerland, with extensive experience in clinical trials and a strong educational background in biotechnology and clinical research.
Current Title and Role
Enrico Bergonzani is currently serving as a Global Trial Manager at Bristol Myers Squibb. He has been in this role since September 2021 and is based in Neuchâtel, Switzerland. His responsibilities include overseeing global clinical trials, ensuring they adhere to protocols, and managing timelines and budgets.
Experience at ICON plc
Enrico Bergonzani accumulated extensive experience in clinical trial management during his tenure at ICON plc. He started as a Clinical Research Associate I (CRA I) in 2016 in Milano, Italia, and progressed through roles including CRA II and Senior CRA, ultimately becoming a Clinical Trial Manager. Over more than four years, he contributed significantly to various clinical trials until he left the company in 2021.
Research Fellow at Georg-Speyer-Haus
Before joining ICON plc, Enrico Bergonzani worked as a Research Fellow at the Chemotherapeutisches Forschungszentrum 'Georg-Speyer-Haus' in Frankfurt am Main. From 2014 to 2015, he gained valuable experience in research, contributing to projects in the area of chemotherapy and related fields.
Academic Background in Biotechnology
Enrico Bergonzani has a strong academic foundation in biotechnology. He obtained a Bachelor’s Degree in Biotechnology from Università degli Studi di Parma, studying there from 2009 to 2012. Following this, he pursued a Master’s Degree in Medical Biotechnology at the same institution, which he completed between 2012 and 2014.
Graduate Certificate in Clinical Research
To further enhance his expertise in clinical research, Enrico Bergonzani earned a Graduate Certificate from University College Dublin. He attended from 2015 to 2016, acquiring advanced knowledge that complements his practical experience in the field of clinical trials.